Scholar Rock Q3 net loss $43.3M ($0.55/share), cash $343.7M, appoints CEO/CMO

Scholar Rock Holding Corp

2022-Q3 EPS reported -$1.80 revenue$33,193,000

Net loss of $43.3M ($0.55/share) vs $37.5M loss in Q3 2021; zero revenue vs $5.5M prior year.
Cash, equivalents, and marketable securities $343.7M as of Sep 30, 2022, expected to fund operations into 2025.
Appointed Jay Backstrom as President & CEO (Oct) and Jing Marantz as CMO (Nov).
Amended debt facility with Oxford/SVB adding $25M capacity, extending interest-only period to Nov 2024 and maturity to Nov 2027.
Phase 3 SAPPHIRE trial for apitegromab enrolling ~156 patients; Phase 1 DRAGON shows confirmed PR in ccRCC.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Scholar Rock Holding Corp reported third quarter ended September 30, 2022 results: revenue $0, net income $43.3 million, EPS $0.55 per share.

Period: third quarter ended September 30, 2022
Revenue: $0
Net income: $43.3 million
EPS: $0.55 per share
Result: reported results

Exact text from the filing

For the quarter ended September 30, 2022, net loss was $43.3 million or $0.55 per share compared to a net loss of $37.5 million or $1.02 per share for the quarter ended September 30, 2021. Revenue was $0 for the quarter ended September 30, 2022, compared to $5.5 million for the quarter ended September 30, 2021.

View on SEC.gov

Browse all earnings releases →

Scholar Rock Holding Corp filing history →

Source: SEC EDGAR

accession 0001157523-22-001608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.